The expansion will create 400 jobs dedicated to GLP-1 injectables production across Resilience’s contract manufacturing facilities.
An article from
Dive Brief
The expansion will create 400 jobs dedicated to GLP-1 injectables production across Resilience’s contract manufacturing facilities.
Published July 31, 2026
Resilience's headquarters in Blue Ash, Cincinnati. The contract manufacturer has invested $750 million with partner Eli Lilly to expand injectable production across its facilities.
Eli Lilly has doubled down on its partnership with CDMO Resilience as the companies embark on a $750 million investment to…
Gerresheimer sells Centor and PPP unit to Apax Funds for €1.5B; Resilience and Lilly invest $750M in Ohio manufacturing; Teva…
The Indianapolis-based company expanded its spend to ensure it can meet growing demand for its weight-loss drugs.
More production capacity for the obesity pill is crucial as Eli Lilly races to bring it to market and tries to maintain its…
Contract manufacturing powerhouse Lonza is growing in more ways than one. | Contract manufacturing powerhouse Lonza is growing in…
The drugmaker announced it will buy three privately held vaccine makers in deals worth almost $4 billion combined.
